Boundless Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $11.5M |
| FY2023 | $9.4M | $129.9M | $23.7M |
| FY2024 | $55.8M | $206.4M | $26.6M |
| FY2025 | $58.4M | $157.1M | $17.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $11.5M |
| FY2023 | $9.4M | $129.9M | $23.7M |
| FY2024 | $55.8M | $206.4M | $26.6M |
| FY2025 | $58.4M | $157.1M | $17.9M |